GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,309.50p
   
  • Change Today:
      9.50p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,300.00
  • Currency: UK Pounds
  • Shares Issued: 4,145.10m
  • Volume: 5,884,408
  • Market Cap: £54,280m
  • RiskGrade: 129
  • Beta: 0.56

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
10-Sep-24 Berenberg Bank Buy 1,671.00p - 1,820.00p Reiteration
03-Sep-24 Deutsche Buy 1,655.00p - 1,850.00p Reiteration
28-Aug-24 Shore Capital Buy 1,651.50p - - Reiteration
29-Jul-24 JP Morgan Cazenove Underweight 1,557.00p - - Reiteration
05-Jul-24 Citigroup Buy 1,511.00p 2,120.00p 1,900.00p Reiteration
27-Jun-24 Jefferies Buy 1,526.00p - 2,100.00p Reiteration
07-May-24 Barclays Equal-weight 1,761.00p - 1,725.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

GSK Market Data

Currency UK Pounds
Share Price 1,309.50p
Change Today 9.50p
% Change 0.73 %
52 Week High 1,812.50
52 Week Low 1,300.00
Volume 5,884,408
Shares Issued 4,145.10m
Market Cap £54,280m
Beta 0.56
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.16% below the market average48.16% below the market average48.16% below the market average48.16% below the market average48.16% below the market average
16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average
Price Trend
36.75% below the market average36.75% below the market average36.75% below the market average36.75% below the market average36.75% below the market average
18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average
Income
47.15% above the market average47.15% above the market average47.15% above the market average47.15% above the market average47.15% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
5.4% below the market average5.4% below the market average5.4% below the market average5.4% below the market average5.4% below the market average
23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average

What The Brokers Say

Strong Buy 7
Buy 4
Neutral 11
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 15-Nov-24 15-Aug-24
Paid 09-Jan-25 10-Oct-24
Amount 15.00p 15.00p

Trades for 21-Nov-2024

Time Volume / Share Price
16:28 1 @ 1,310.50p
16:24 0 @ 1,311.00p
16:20 47 @ 1,310.00p
16:09 40 @ 1,308.50p
15:47 4 @ 1,306.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page